Literature DB >> 7871753

Growth-restricted dengue virus mutants containing deletions in the 5' noncoding region of the RNA genome.

A Cahour1, A Pletnev, M Vazielle-Falcoz, L Rosen, C J Lai.   

Abstract

The dengue type 4 virus (DEN4) RNA genome contains a 101-nt 5' noncoding (NC) sequence which is predicted to form a stable secondary structure. DEN4 cDNA from which infectious RNA can be transcribed was used to engineer deletions in the 5' NC region for functional analysis of RNA structure and for isolation of DEN4 mutants that could be evaluated as candidates for use in a live attenuated vaccine. Eleven distinct deletions in the region of the DEN4 genome between nts 18 and 98 were constructed; each mutation was predicted to alter or disrupt the local base-parings in the 5' NC RNA structure. An infectious virus was not recovered from the RNA transcripts of five of these deletion mutants. Significantly, four of the five apparently lethal deletions were located in a 5- to 6-nt base-paired region of a predicted long stem or adjacent to it. In contrast, with one exception, mutants which yielded infectious virus had deletions which were located in a loop or short stem region. The effect of the deletions on the efficiency of translation of viral RNA transcripts was examined in vitro. The RNA transcripts of deletion constructs which did not yield viable virus were translated at an efficiency ranging from 40 to 160% that of wild-type virus transcripts. The translation efficiency of infectious RNA transcripts also varied. Deletion mutants recovered from RNA transcripts that exhibited low to moderate efficiency of translation had a small plaque morphology and exhibited reduced growth in simian LLC-MK2 and mosquito C6/36 cells compared to the wild-type virus. Among the 11 mutant constructs, deletion of nts 82-87 caused the greatest reduction in translation efficiency. Nevertheless, an infectious virus was recovered from LLC-MK2 cells transfected with the RNA transcripts of mutant d(82-87). The progeny of this mutant produced small plaques on LLC-MK2 cells and grew to low titer in these cells. Unlike wild-type DEN4 or other DEN4 deletion mutants tested, mutant d(82-87) failed to produce plaques on C6/36 cells and was also replication-defective in Aedes aegypti and Aedes albopictus following intrathoracic inoculation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7871753     DOI: 10.1006/viro.1995.1052

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  52 in total

1.  Attenuation of Murray Valley encephalitis virus by site-directed mutagenesis of the hinge and putative receptor-binding regions of the envelope protein.

Authors:  R J Hurrelbrink; P C McMinn
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

2.  Essential role of cyclization sequences in flavivirus RNA replication.

Authors:  A A Khromykh; H Meka; K J Guyatt; E G Westaway
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

3.  Cellular proteins from human monocytes bind to dengue 4 virus minus-strand 3' untranslated region RNA.

Authors:  Rosa Martha E Yocupicio-Monroy; Fernando Medina; Jorge Reyes-del Valle; Rosa M del Angel
Journal:  J Virol       Date:  2003-03       Impact factor: 5.103

4.  Cell proteins TIA-1 and TIAR interact with the 3' stem-loop of the West Nile virus complementary minus-strand RNA and facilitate virus replication.

Authors:  W Li; Y Li; N Kedersha; P Anderson; M Emara; K M Swiderek; G T Moreno; M A Brinton
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

5.  Identification of cis-acting elements in the 3'-untranslated region of the dengue virus type 2 RNA that modulate translation and replication.

Authors:  Mark Manzano; Erin D Reichert; Stephanie Polo; Barry Falgout; Wojciech Kasprzak; Bruce A Shapiro; Radhakrishnan Padmanabhan
Journal:  J Biol Chem       Date:  2011-04-22       Impact factor: 5.157

6.  Dengue 2 PDK-53 virus as a chimeric carrier for tetravalent dengue vaccine development.

Authors:  Claire Y-H Huang; Siritorn Butrapet; Kiyotaka R Tsuchiya; Natth Bhamarapravati; Duane J Gubler; Richard M Kinney
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

7.  RNA sequences and structures required for the recruitment and activity of the dengue virus polymerase.

Authors:  Claudia V Filomatori; Nestor G Iglesias; Sergio M Villordo; Diego E Alvarez; Andrea V Gamarnik
Journal:  J Biol Chem       Date:  2010-12-23       Impact factor: 5.157

8.  Attenuation markers of a candidate dengue type 2 vaccine virus, strain 16681 (PDK-53), are defined by mutations in the 5' noncoding region and nonstructural proteins 1 and 3.

Authors:  S Butrapet; C Y Huang; D J Pierro; N Bhamarapravati; D J Gubler; R M Kinney
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

9.  Chimeric dengue type 2 (vaccine strain PDK-53)/dengue type 1 virus as a potential candidate dengue type 1 virus vaccine.

Authors:  C Y Huang; S Butrapet; D J Pierro; G J Chang; A R Hunt; N Bhamarapravati; D J Gubler; R M Kinney
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

10.  Chimeric dengue 2 PDK-53/West Nile NY99 viruses retain the phenotypic attenuation markers of the candidate PDK-53 vaccine virus and protect mice against lethal challenge with West Nile virus.

Authors:  Claire Y-H Huang; Shawn J Silengo; Melissa C Whiteman; Richard M Kinney
Journal:  J Virol       Date:  2005-06       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.